Tag Archive for: commercialization rights

Japan’s Takeda Pharmaceutical gave India’s Sun Pharmaceutical and Cipla the rights to commercialize the gastrointestinal drug Vonoprazan in the country.

Roche is returning the global development and commercialization rights to the investigational cancer asset camonsertib to Repare Therapeutics, the Cambridge, Mass. and Montreal-based oncology company announced Monday.